| Name | Title | Contact Details |
|---|
Thornhill Research Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cor is a powerful general wellness product that delivers personalized health insights from a single drop of blood. The Cor Reader uses patented vibrational spectroscopic technology to analyze a surface-level blood sample and report overall trends. The Cor App then delivers key insights and lifestyle improvement recommendations related to indicators such as cholesterol, fasting blood glucose, inflammation and triglycerides. Cor was founded in 2014 by Bob Messerschmidt and is backed by world-class medical advisors from Stanford, UCSF and Duke University.
Neuroplasticity targeting electrical fields delivered by a wearable interface, to help the brain regain control of immune function
Cure Alzheimers Fund is a non-profit organization that funds targeted research with the highest probability of preventing, slowing, or reversing Alzheimers disease.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.